Press Releases Shield Therapeutics plc

Equities

Market Closed - London S.E. Other stock markets 11:35:09 2024-06-06 am EDT			5-day change	1st Jan Change
2 ^GBX	+8.11%		-6.98%	-70.15%

May. 28	NetScientific backs Wanda; Inspirit Energy wins deal	AN
May. 10	Shield Therapeutics plc Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Hardman & Co: Shield Therapeutics (STX): Cash management is key	May. 23	EQ
Shield Therapeutics : 2023 Annual Report and Accounts	May. 10	PU
Shield Therapeutics : Notice of Annual General Meeting 2024	May. 10	PU
Shield Therapeutics : Letter to Shareholders 2024	May. 10	PU
Hardman & Co Research on Shield Therapeutics (STX): Accelerating effectiveness of enlarged sales team	Nov. 15	EQ
Shield to Present Abstract at 26th Annual Women's Healthcare Conference 2023 on Accrufer	23-10-23	AQ
Shield Therapeutics' pricing will be "key metric" - Proactive Research Analyst	23-10-05	AQ
Shield Therapeutics "couldn't be more pleased" with Viatris collaboration	23-10-05	AQ
Shield Therapeutics : Launch Announcement	23-09-28	PU
Proactive Research Analyst says Shield Therapeutics' commercialisation drive "going well"	23-08-01	AQ
Shield Therapeutics "really starting to fire on all cylinders"	23-07-25	AQ
Shield Therapeutics : Notice of Annual General Meeting 2023	23-05-19	PU
Shield Therapeutics : 2022 Annual Report and Accounts	23-05-19	PU
Shield Therapeutics : Letter to Shareholders	23-05-19	PU
Premier Miton Group Plc - Form 8.3 - Shield Therapeutics plc	23-05-09	PR
Form 8.3 - Shield Therapeutics plc	23-05-09	AQ
Killik & Co. LLP - Form 8.3 - Shield Therapeutics Plc	23-05-09	PR
Killik & Co. LLP - Form 8.3 - Shield Therapeutics Plc	23-05-05	PR
Shield Therapeutics : Rule 2.11 Letter to Employees	23-05-04	PU
Shield Therapeutics plc - Appointment of Chief Commercial Officer	23-04-06	AQ

No results for this search